vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and POTLATCHDELTIC CORP (PCH). Click either name above to swap in a different company.
POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 23.1%). Over the past eight quarters, POTLATCHDELTIC CORP's revenue compounded faster (11.1% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
POTLATCHDELTIC CORPPCHEarnings & Financial Report
PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.
ESPR vs PCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $314.2M |
| Net Profit | — | $25.9M |
| Gross Margin | — | 18.2% |
| Operating Margin | 50.6% | 11.2% |
| Net Margin | — | 8.2% |
| Revenue YoY | 143.7% | 23.1% |
| Net Profit YoY | — | 682.5% |
| EPS (diluted) | $0.32 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | $314.2M | ||
| Q2 25 | $82.4M | $275.0M | ||
| Q1 25 | $65.0M | $268.3M | ||
| Q4 24 | $69.1M | $258.1M | ||
| Q3 24 | $51.6M | $255.1M | ||
| Q2 24 | $73.8M | $320.7M | ||
| Q1 24 | $137.7M | $228.1M |
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $25.9M | ||
| Q2 25 | $-12.7M | $7.4M | ||
| Q1 25 | $-40.5M | $25.8M | ||
| Q4 24 | — | $5.2M | ||
| Q3 24 | $-29.5M | $3.3M | ||
| Q2 24 | $-61.9M | $13.7M | ||
| Q1 24 | $61.0M | $-305.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 13.0% | ||
| Q1 25 | — | 17.8% | ||
| Q4 24 | — | 13.4% | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 11.9% | ||
| Q1 24 | — | 7.0% |
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | 11.2% | ||
| Q2 25 | 8.6% | 5.0% | ||
| Q1 25 | -34.0% | 10.3% | ||
| Q4 24 | -6.4% | 5.2% | ||
| Q3 24 | -31.0% | 2.8% | ||
| Q2 24 | 3.5% | 5.4% | ||
| Q1 24 | 52.5% | -2.1% |
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | 8.2% | ||
| Q2 25 | -15.4% | 2.7% | ||
| Q1 25 | -62.2% | 9.6% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | -57.2% | 1.3% | ||
| Q2 24 | -83.9% | 4.3% | ||
| Q1 24 | 44.3% | -0.1% |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | $0.33 | ||
| Q2 25 | $-0.06 | $0.09 | ||
| Q1 25 | $-0.21 | $0.33 | ||
| Q4 24 | $-0.14 | $0.07 | ||
| Q3 24 | $-0.15 | $0.04 | ||
| Q2 24 | $-0.33 | $0.17 | ||
| Q1 24 | $0.34 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $88.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $1.9B |
| Total Assets | $465.9M | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | $88.8M | ||
| Q2 25 | $86.1M | $95.3M | ||
| Q1 25 | $114.6M | $147.5M | ||
| Q4 24 | $144.8M | $151.6M | ||
| Q3 24 | $144.7M | $161.1M | ||
| Q2 24 | $189.3M | $199.7M | ||
| Q1 24 | $226.6M | $180.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | $1.9B | ||
| Q2 25 | $-433.5M | $1.9B | ||
| Q1 25 | $-426.2M | $2.0B | ||
| Q4 24 | $-388.7M | $2.0B | ||
| Q3 24 | $-370.2M | $2.1B | ||
| Q2 24 | $-344.2M | $2.1B | ||
| Q1 24 | $-294.3M | $2.2B |
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | $3.2B | ||
| Q2 25 | $347.1M | $3.2B | ||
| Q1 25 | $324.0M | $3.3B | ||
| Q4 24 | $343.8M | $3.3B | ||
| Q3 24 | $314.1M | $3.3B | ||
| Q2 24 | $352.3M | $3.4B | ||
| Q1 24 | $373.1M | $3.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $65.7M |
| Free Cash FlowOCF − Capex | — | $50.1M |
| FCF MarginFCF / Revenue | — | 15.9% |
| Capex IntensityCapex / Revenue | 0.0% | 4.9% |
| Cash ConversionOCF / Net Profit | — | 2.54× |
| TTM Free Cash FlowTrailing 4 quarters | — | $132.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $65.7M | ||
| Q2 25 | $-31.4M | $41.0M | ||
| Q1 25 | $-22.6M | $49.1M | ||
| Q4 24 | $-35.0M | $45.4M | ||
| Q3 24 | $-35.3M | $26.5M | ||
| Q2 24 | $-7.2M | $100.6M | ||
| Q1 24 | $53.8M | $16.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $50.1M | ||
| Q2 25 | — | $30.6M | ||
| Q1 25 | — | $26.3M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | $-35.5M | $-8.2M | ||
| Q2 24 | $-7.3M | $72.4M | ||
| Q1 24 | $53.8M | $2.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 15.9% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | -68.7% | -3.2% | ||
| Q2 24 | -9.9% | 22.6% | ||
| Q1 24 | 39.0% | 0.9% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 4.9% | ||
| Q2 25 | 0.0% | 3.8% | ||
| Q1 25 | 0.0% | 8.5% | ||
| Q4 24 | 0.0% | 7.7% | ||
| Q3 24 | 0.3% | 13.6% | ||
| Q2 24 | 0.1% | 8.8% | ||
| Q1 24 | 0.1% | 6.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 5.58× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 8.74× | ||
| Q3 24 | — | 7.99× | ||
| Q2 24 | — | 7.35× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
